- Home
- SYNX vs HOOK Comparison
SYNX vs HOOK Comparison
Compare SYNX & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- HOOK
- Stock Information
- Founded
- SYNX 2005
- HOOK 2011
- Country
- SYNX Israel
- HOOK United States
- Employees
- SYNX N/A
- HOOK N/A
- Industry
- SYNX
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- HOOK Health Care
- Exchange
- SYNX Nasdaq
- HOOK Nasdaq
- Market Cap
- SYNX 20.8M
- HOOK 24.5M
- IPO Year
- SYNX 2024
- HOOK 2019
- Fundamental
- Price
- SYNX $3.85
- HOOK $1.78
- Analyst Decision
- SYNX
- HOOK Buy
- Analyst Count
- SYNX 0
- HOOK 4
- Target Price
- SYNX N/A
- HOOK $10.67
- AVG Volume (30 Days)
- SYNX 3.2K
- HOOK 44.7K
- Earning Date
- SYNX 10-02-2024
- HOOK 03-21-2025
- Dividend Yield
- SYNX N/A
- HOOK N/A
- EPS Growth
- SYNX N/A
- HOOK N/A
- EPS
- SYNX N/A
- HOOK N/A
- Revenue
- SYNX $9,893,000.00
- HOOK $49,999,000.00
- Revenue This Year
- SYNX $52.34
- HOOK $148.80
- Revenue Next Year
- SYNX N/A
- HOOK N/A
- P/E Ratio
- SYNX N/A
- HOOK N/A
- Revenue Growth
- SYNX 18.05
- HOOK 143.30
- 52 Week Low
- SYNX $2.10
- HOOK $1.65
- 52 Week High
- SYNX $6.49
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- SYNX 45.82
- HOOK 41.23
- Support Level
- SYNX $3.60
- HOOK $1.77
- Resistance Level
- SYNX $4.10
- HOOK $1.96
- Average True Range (ATR)
- SYNX 0.26
- HOOK 0.12
- MACD
- SYNX -0.04
- HOOK 0.00
- Stochastic Oscillator
- SYNX 47.59
- HOOK 41.40
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.